Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Advocates seek more say in how opioid settlements are spent

As billions of dollars in opioid lawsuit settlements are starting to flow to governments, families and advocates impacted by the opioid crisis are pushing for a meaningful say in how the money will be used

The Independent UK

1 Biotech Stock That Has Fallen Hard in 2022

Biotech stock Timber Pharmaceuticals (TMBR) is down more than 70% year-to-date. Analysts expect it to keep reporting losses over the next two years. So, will it be wise to buy the stock now? Read on to learn our view….

StockNews.com

Suspected drug deaths in first six months of year 22 per cent lower than last year

The number of suspected drug deaths in Scotland in the first six months of this year has dropped by 22 compared to last year.

The National (Scotland)

From analysis to the latest developments in health,
read the most diverse news in one place.

Pharma Giants Moderna And Novavax Trend Lower In This Pattern: What's Going On?

Moderna Inc. (NASDAQ: MRNA) and Novavax Inc. (NASDAQ: NVAX) were trading down over 2% and 4%, respectively in the premarket Friday despite both stocks showing signs a bounce could be in the cards.

Benzinga

1 Stock Under $65 That You Shouldn't Ignore

Leading biopharmaceutical company Gilead Sciences (GILD) reported impressive sales in the last quarter and raised its full-year 2022 guidance. Furthermore, the company’s strategic acquisitions, drug approvals, and research breakthroughs should drive its growth in the coming quarters. Given GILD’s discounted valuation, we think it could be wise to buy this…

StockNews.com

Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test

Ionis stock tumbled Friday after partner AstraZeneca decided against sending their high cholesterol treatment into Phase 3 testing.

Investors Business Daily

FDA reminds people not to cook chicken in Nyquil after ‘dangerous’ social media trend resurfaces

‘These video challenges, which often target youths, can harm people — and even cause death,’ the agency said

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

4.4M Americans roll up sleeves for omicron-targeted boosters

More than 4 million Americans have rolled up their sleeves for the new omicron-specific booster shots

The Independent UK

U.S. cutting global donations of Pfizer COVID shots as demand slows

The United States is significantly cutting back the number of Pfizer/BioNTech COVID-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries.

Reuters

Pfizer, US revise contract for donated vaccines as world demand plummets

WASHINGTON — President Joe Biden’s administration has slashed its target for COVID-19 vaccine donations abroad this year, amending a contract with Pfizer Inc. in the latest sign that world demand for the shots has collapsed.

Tribune News Service

Lawmakers strike deal on FDA user fee bill

WASHINGTON — Senate committee leaders have struck an agreement to reauthorize five-year user fee deals for the Food and Drug Administration, although details of a broader stopgap government spending bill remain unfinished.

Tribune News Service

Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs

Merck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris over an ingredient used in diabetes meds.

Investors Business Daily

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session

Gainers

Benzinga

Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak

Novavax stock is trading at a two-year low amid slowly ramping use of its Covid vaccine, dubbed Nuvaxovid, in the U.S.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Liverpool Echo

Men ran Breaking Bad style drugs lab worth up to £10m a month

Keith Davis and Andrew Gurney have had their 'lenient' jail sentences extended

Benzinga

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.

The Independent UK

France to make morning after pill free for all women and girls

Free screening for sexually transmitted infections for all young people is also being extended

The Independent UK

Two men who ran £11m Breaking Bad-style meth amphetamine lab have ‘lenient’ sentences increased

Operation produced up amphetamine sulphate and was one of the largest factories ever found in the UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Experts raise concern over ‘diet pills’ promoted on social media

TikTok branded ‘worst culprit’ for bombarding users with misinformation

The Independent UK

FDA reminds people not to cook chicken in Nyquil after ‘dangerous’ TikTok trend resurfaces

‘These video challenges, which often target youths, can harm people — and even cause death,’ the agency said

AFP

Global Fund raises $14.25 billion to end HIV, TB and malaria

New York (AFP) - The Global Fund to Fight AIDS, Tuberculosis and Malaria raised $14.25 billion Wednesday at a donor conference led by US President Joe Biden, as decades of progress against the diseases are set back by Covid.

Daily Record

Hamilton Accies Community Trust in cash boost from global pharmaceutical firm

AstraZeneca is supporting the work the Trust does across the Lanarkshire community.

Benzinga

Lepu ScienTech Revives IPO After Policy Move Brightens Its Prospects

Key Takeaways: After taking its Lepu Biopharma unit public in February, Lepu Medical is pressing ahead with a third attempt at listing is Lepu ScienTech unit in Hong Kong

Benzinga

IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC

India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”

WEKU

FDA seems poised to approve a new drug for ALS, but does it work?

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

1 … 125 126 127 128

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

329 stories

GSK

316 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.